Gosselies, Belgium, 6 May 2020, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to address high unmet medical needs in orthopaedics and bone diseases, today provides a business update for the first quarter ended 31 March 2020. “Bone Therapeutics has experienced …